Approval · Notice of Compliance 25566 · 2021
PUREGON: Notice of Compliance 25566
Issued March 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25566
- Date
- March 26, 2021
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PUREGON | 02243948 | Marketed |
| PUREGON | Not yet assigned | — |
Medicinal ingredients
- FOLLITROPIN BETA 100 UNIT per 0.5ML
- FOLLITROPIN BETA 250 UNIT per CART
- FOLLITROPIN BETA 650 UNIT per CART
- FOLLITROPIN BETA 950 UNIT per CART